Tag Archives: GBM

For a long time, we’ve kept Northwest Biotherapeutics, Inc (OTCMKTS:NWBO) on our radar. The company has been one of the hardest stocks to read over the last eighteen months, rooted in a clinical hold on its lead asset, and sentiment surrounding...

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) is one of the week’s biggest biotech runners, up close to 200% on the Monday open. At a glance, there doesn’t look to be too much we can pin the gains on – there has been no news...

Northwest Biotherapeutics, Inc (NASDAQ:NWBO) shareholders have been waiting for some level of insight into its brain cancer trial for more than twelve months. Since enrollment came to a halt last year, the company has refused (or been unable,...

Northwest Biotherapeutics, Inc (NASDAQ:NWBO) just announced that it is voluntarily delisting its stock from NASDAQ in favor of an over the counter listing, and markets have responded positively to the news. The general view of a delisting is...

Well, here’s one for the books. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) just put out a fresh press release, updating markets as to the progress of its operations. Well, sort of. We didn’t get too much information on the current...

DelMar Pharmaceuticals Inc (NASDAQ:DMPI) will ring the bell at NASDAQ HQ this morning to celebrate its recent up listing from OTC. The company has been riding high since it reported the advance and is up currently about 130% on the year after...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter